As we have discussed, social distancing, both prolonged one-time and intermittent, buys the healthcare system time to adapt to the outbreak. Importantly, social distancing also buys physicians and scientists time to test and optimize the efficacy of new therapies to treat COVID-19 patients, thereby reducing the percent of those patients requiring critical care and the disease mortality. As we face the long term, however, we may aim to target interventions more precisely - progressing from mitigation to suppression.